Treatment Failure in Scabies: Assessment of Risk Factors in a Multicenter Cross-Sectional Study

Yasemin Erdem; Algun  Polat Ekinci; Mucahit Ergun; Ceylan Bulat; Artun Kırker; Hamit Dogus Turgut; Afra Cesur; Ilknur Kıvanc Altunay; Zeynep Topkarci

doi:10.5826/dpc.1504a5360

Treatment Failure in Scabies: Assessment of Risk Factors in a Multicenter Cross-Sectional Study

Authors

Yasemin Erdem Istanbul University, Istanbul Faculty of Medicine, Department of Dermatology and Venereology, Istanbul, Turkey https://orcid.org/0000-0002-6597-2957
Algun Polat Ekinci Istanbul University, Istanbul Faculty of Medicine, Department of Dermatology and Venereology, Istanbul, Turkey https://orcid.org/0000-0003-4056-8402
Mucahit Ergun Istanbul University, Istanbul Faculty of Medicine, Department of Dermatology and Venereology, Istanbul, Turkey
Ceylan Bulat Health Science University, Sisli Hamidiye Etfal Training and Research Hospital, Department of Dermatology, Istanbul, Turkey
Artun Kırker Health Science University, Sisli Hamidiye Etfal Training and Research Hospital, Department of Dermatology, Istanbul, Turkey
Hamit Dogus Turgut Istanbul University, Istanbul Faculty of Medicine, Department of Dermatology and Venereology, Istanbul, Turkey
Afra Cesur Health Science University, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Dermatology, Istanbul, Turkey
Ilknur Kıvanc Altunay Health Science University, Sisli Hamidiye Etfal Training and Research Hospital, Department of Dermatology, Istanbul, Turkey
Zeynep Topkarci Health Science University, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of Dermatology, Istanbul, Turkey

Keywords:

scabies, treatment failure, treatment succesful, permethrin

Abstract

Introduction: Recent reports of increased prevalence and treatment failure in scabies have raised concerns worldwide. Drug efficacy as well as adherence to treatment are important in treatment failure, and data on the latter are limited.

Objective: We aimed to determine the factors associated with treatment failure in scabies.

Methods: This prospective, multicenter observational study was conducted in three centers, enrolling 230 patients diagnosed with scabies. Treatment outcomes were assessed one month after treatment initiation. Patients completed a questionnaire evaluating factors potentially affecting treatment outcomes. Demographic and clinical characteristics and adherence to treatment recommendations were compared in two groups: successful treatment and treatment failure.

Results: The study included 125 males and 105 females, with a mean age of 24.6 ±17.6 years. Treatment failure was found in 58 patients (25.2%). No demographic parameter or medication was associated with treatment failure. Three independent risk factors for treatment failure (multivariate regression analysis) were lack of application of topical medication to the whole body, (odds ration (OR): 14.33; 95% confidence interval (CI): 2.9–71.4), lack of reapplication after washing hands (OR: 3.5; 95% CI: 1.5–8.0), and not reading of the information form (OR: 13.7; 95% CI: 1.3–80.6).

Conclusion: Treatment failure in scabies is quite common. Incorrect or incomplete application of topical treatment and lack of hygiene measures are the main factors leading to treatment failure. Providing a written information sheet with step-by-step treatment recommendations may contribute to treatment success.

References

https://www.who.int/news-room/fact-sheets/detail/scabies

Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31(8):1248-1253. DOI: 10.1111/jdv.14351. PMID: 28639722.

Van Deursen B, Hooiveld M, Marks S, et al. Increasing incidence of reported scabies infestations in the Netherlands, 2011-2021. PLoS One. 2022;17(6):e0268865. DOI: 10.1371/journal.pone.0268865. PMID: 35749401.

Redondo-Bravo L, Fernandez-Martinez B, Gómez-Barroso D, et al. Scabies in Spain? A comprehensive epidemiological picture. PLoS One. 2021;16(11):e0258780. DOI: 10.1371/journal.pone.0258780. PMID: 34723979.

Baykal C, Atci T, Kutlay A, Baykut B, Türkoğlu Z. Scabies outbreak in Turkey in 2018-2019. J Eur Acad Dermatol Venereol. 2021;35(6):e384-e385. DOI: 10.1111/jdv.17152. PMID: 33539599.

Özden MG, Ertürk K, Kartal SP, et al. An extraordinary outbreak of scabies in Turkey. J Eur Acad Dermatol Venereol. 2020;34(12):e818-e820. DOI: 10.1111/jdv.16699. PMID: 32491243.

Mbuagbaw L, Sadeghirad B, Morgan RL, Mertz D, et al. Failure of scabies treatment: a systematic review and meta-analysis. Br J Dermatol. 2024;190(2):163-173. DOI: 10.1093/bjd/ljad308. PMID: 37625798.

Aussy A, Houivet E, Hébert V, et al; investigators from the Normandy Association of Medical Education in Dermatology. Risk factors for treatment failure in scabies: a cohort study. Br J Dermatol. 2019;180(4):888-893. DOI: 10.1111/bjd.17348. PMID: 30376179.

Lee SK, Kim JH, Kim MS, Lee UH. Risk factors for scabies treatment resistance: a retrospective cohort study. J Eur Acad Dermatol Venereol. 2022;36(1):126-132. DOI: 10.1111/jdv.17713. PMID: 34592030.

Makigami K, Ohtaki N, Ishii N, Tamashiro T, Yoshida S, Yasumura S. Risk factors for recurrence of scabies: a retrospective study of scabies patients in a long-term care hospital. J Dermatol. 2011 Sep;38(9):874-9. DOI: 10.1111/j.1346-8138.2011.01199.x. PMID: 21658115.

De Sainte Marie B, Mallet S, Gaudy-Marqueste C, et al. Gales en échec de traitement : étude observationnelle [Therapeutic failure in scabies: An observational study]. Ann Dermatol Venereol. 2016;143(1):9-15. DOI: 10.1016/j.annder.2015.10.588. PMID: 26651923.

Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020;183(5):808-820. DOI: 10.1111/bjd.18943.

Sunderkötter C, Aebischer A, Neufeld M, at al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J Dtsch Dermatol Ges. 2019;17(1):15-23. DOI: 10.1111/ddg.13706. PMID: 30480868.

Sunderkötter C, Feldmeier H, Fölster-Holst R, et al. S1 guidelines on the diagnosis and treatment of scabies - short version. J Dtsch Dermatol Ges. 2016;14(11):1155-1167. DOI: 10.1111/ddg.13130. PMID: 27879074.

Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Guideline for the diagnosis and treatment of scabies in Japan (third edition): Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. J Dermatol. 2017;44(9):991-1014. DOI: 10.1111/1346-8138.13896. Epub 2017 May 31. PMID: 28561292.

Uzun S, Durdu M, Yürekli A, et al. Clinical practice guidelines for the diagnosis and treatment of scabies. Int J Dermatol. 2024 Jun 23. DOI: 10.1111/ijd.17327. PMID: 38922701.

Ulff E, Maroti M, Kettis-Lindblad A, et al. Single application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sites. Br J Dermatol. 2007;156(5):974-8. DOI: 10.1111/j.1365-2133.2007.07754.x. PMID: 17316365.

Nemecek R, Stockbauer A, Lexa M, Poeppl W, Mooseder G. Application errors associated with topical treatment of scabies: an observational study. J Dtsch Dermatol Ges. 2020;18(6):554-559. DOI: 10.1111/ddg.14122. PMID: 32469466.

Meyersburg D, Kaiser A, Bauer JW. 'Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study'. J Dermatolog Treat. 2022;33(2):774-777. DOI: 10.1080/09546634.2020.1774489. PMID: 32495666.

Balestri R, Magnano M, Infusino SD, Rizzoli L, Girardelli CR, Rech G. Scabies is becoming less sensitive to permethrin therapy. J Eur Acad Dermatol Venereol. 2021;35(12):e889-e891. DOI: 10.1111/jdv.17538. PMID: 34310767.

Currie BJ, Harumal P, McKinnon M, Walton SF. First Documentation of In Vivo and In Vitro Ivermectin Resistance in Sarcoptes scabiei. Clin Infect Dis. 2004;39:e8–e12. DOI: 10.1086/421776.

Yürekli A. Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on Sarcoptes scabiei from patients with resistant scabies. Dermatol Ther. 2022;35(3):e15260. DOI: 10.1111/dth.15260. PMID: 34897912.